Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with Chemotherapy in Advanced NSCLC
NCT01041781Phase 3Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Feb 2010
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib oral solution in non-small cell lung cancer (NSCLC), sponsored by Cancer and Leukemia Group B. Started Feb 2010; status: terminated.
02
Drugs
celecoxib oral solution
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01041781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01041781.